Contact this trialFirst, we need to learn more about you.
Immunotherapy
Nivolumab + BMS-986205 for Endometrial Cancer
Recruiting1 awardPhase 2
Harrison, New York
This trial will compare the effects of the immunotherapy drug nivolumab, with or without the experimental drug BMS-986205. The addition of BMS-986205 to nivolumab may improve treatment results, but may also cause side effects.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service